| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0055 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |